Polysciences announces new bioprocessing brand ‘Kyfora Bio’
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The company is one of the most profitable companies manufacturing speciality chemicals in India
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
All claims against the company in the litigation have now been dismissed.
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The new facility will be able to handle four times as many patients as the previous facility.
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Subscribe To Our Newsletter & Stay Updated